NOVELTY – Pharmaceutical formulation comprises standardized extract of Pterodon pubescens. Extract is microencapsulated by utilizing pharmaceutically acceptable vehicle. USE – Pharmaceutical formulation used for treating acute or chronic musculoskeletal conditions associated with pain and inflammation such as dislocations, edema, arthritis and trauma. ADVANTAGE – The pharmaceutical formulation is stable, ensures maximum pharmacological effect, and has uniform spherical structure and wide applicability. The pharmaceutical formulation is suitable for continuous production in large volumes.
A96 (Medical, dental, veterinary, cosmetic.); B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.)